SCHEMBL31716637

SCHEMBL31716637

COc1cc2nc(Cc3cn[nH]c3)[nH]c(=O)c2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.57
GAA P10253 1/20 0.57
LMNA P02545 4/20 0.53
TDP1 Q9NUW8 1/20 0.52
MAPK1 P28482 2/20 0.50
ALDH1A1 P00352 2/20 0.50
PDE3B Q13370 2/20 0.50
PDE3A Q14432 2/20 0.50
USP2 O75604 1/20 0.50
ALOX15 P16050 1/20 0.50
MAPT P10636 2/20 0.49
ROCK2 O75116 1/20 0.48
THRB P10828 1/20 0.47
CASP1 P29466 1/20 0.44
HBB P68871 1/20 0.44
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27167377 0.78 KDM4E (0.72) KDM4EGAALMNATDP1MAPK1
Hydrochloric Acid SCHEMBL31716999 0.78 ROCK2 (0.49) KDM4EGAALMNATDP1MAPK1
SCHEMBL24792433 0.77 KDM4E (0.67) KDM4EGAALMNATDP1MAPK1
SCHEMBL2722552 0.77 KDM4E (0.67) KDM4EGAALMNATDP1MAPK1
SCHEMBL29900596 0.77 KDM4E (0.67) KDM4EGAALMNATDP1MAPK1
SCHEMBL2722306 0.77 KDM4E (0.67) KDM4EGAALMNATDP1MAPK1
SCHEMBL31716646 0.76 KDM4E (0.50) KDM4EGAALMNATDP1MAPK1
SCHEMBL6120242 0.75 KDM4E (0.71) KDM4EGAALMNATDP1MAPK1
SCHEMBL31716546 0.74 KDM4E (0.48) KDM4EGAALMNATDP1MAPK1
SCHEMBL31716235 0.74 PDE10A (0.51) KDM4EGAALMNATDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 WO disclosed